GlassScriptPhysician profile
Craig R Marsh
NPI 1922112515
$185.45
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $48.33 · 2021: $40.13 · 2022: $96.99.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $73.85 | 2021-2022 | |
| Grt US Holding, INC. | $19.77 | 2022 | |
| Novo Nordisk INC | $17.78 | 2020 | |
| Amgen INC. | $16.63 | 2020 | |
| Smith+Nephew, INC. | $16.28 | 2021 | |
| Medtronic, INC. | $14.22 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.92 | 2020 | |
| Depuy Synthes Sales INC. | $13.00 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Marsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.